TWY.STU Alibaba Health Information Technology Limited
- Market cap
- EUR 5.12B
- P/E
- 31.7x
- P/B
- 2.14x
- ROE
- 10.8%
- Dividend yield
- 2.39%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is TWY.STU undervalued?
Graham numberTWY.STU trades 73.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Alibaba Health Information Technology Limited fundamental analysis
No fundamental analysis for Alibaba Health Information Technology Limited yet.
Alibaba Health Information Technology Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-rela…
Full company profileAlibaba Health Information Technology Limited financial statements
Alibaba Health Information Technology Limited annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 475M | 2.44B | 5.10B | 9.60B | 15.5B | 20.6B | 26.8B | 27.0B | 30.6B | 34.3B |
| Gross Profit | 187M | 653M | 1.33B | 2.23B | 3.62B | 4.11B | 5.70B | 5.90B | 7.43B | 8.21B |
| Operating Income | -198M | -129M | -93.3M | -42.2M | 111M | -1.02B | 51.2M | 712M | 1.58B | 1.89B |
| EBITDA | - | -80.5M | -28.9M | 72.7M | 404M | -249M | 621M | 999M | 1.62B | 2.33B |
| Net Income | -208M | -107M | -81.9M | -6.59M | 349M | -266M | 536M | 883M | 1.43B | 1.94B |
| EPS | -0.03 | -0.01 | -0.01 | 0.00 | 0.03 | -0.02 | 0.04 | 0.05 | 0.09 | 0.12 |
| Balance Sheet | ||||||||||
| Total Assets | 1.68B | 3.11B | 5.98B | 7.87B | 17.7B | 19.2B | 20.7B | 19.7B | 21.2B | 23.1B |
| Total Liabilities | 560M | 588M | 3.25B | 2.67B | 3.46B | 5.13B | 5.60B | 5.19B | 4.87B | 5.24B |
| Shareholders' Equity | 1.18B | 2.58B | 2.79B | 5.27B | 14.3B | 14.1B | 15.2B | 14.5B | 16.3B | 17.9B |
| Cash & Short-term Investments | 570M | 508M | 280M | 2.59B | 11.6B | 10.5B | 10.9B | 9.55B | 2.22B | 5.43B |
| Cash Flow | ||||||||||
| Operating Cash Flow | -226M | -70.3M | 396M | 584M | 1.01B | 424M | 256M | 1.08B | 1.40B | 1.24B |
| Capital Expenditure | 2.14M | 5.73M | 6.10M | 7.57M | 17.1M | 14.9M | 5.92M | 22.8M | 18.9M | 8.99M |
| Free Cash Flow | - | -76.0M | 390M | 570M | 1.01B | 424M | 256M | 1.06B | 1.38B | 1.23B |
| Ratios | ||||||||||
| ROE | -17.6% | -4.1% | -2.9% | -0.1% | 2.4% | -1.9% | 3.5% | 6.1% | 8.8% | 10.8% |
| ROA | -12.4% | -3.4% | -1.4% | -0.1% | 2.0% | -1.4% | 2.6% | 4.5% | 6.8% | 8.4% |
| Net Profit Margin | -43.7% | -4.4% | -1.6% | -0.1% | 2.2% | -1.3% | 2.0% | 3.3% | 4.7% | 5.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Alibaba Health Information Technology Limited dividends
- Dividend yield
- 2.39%
- Forward dividend
- 0.01 EUR
- Payout ratio
- -
- Ex-dividend date
- Aug 12, 2026
Who owns Alibaba Health Information Technology Limited
- Insiders 63.52%
- Institutions 14.33%
- Public & others 22.14%
- Shares outstanding 16.2B
- Free float 5.87B
Alibaba Health Information Technology Limited company profile
- Company name
- Alibaba Health Information Technology Limited
- Ticker
- TWY.STU
- ISIN
- BMG0171K1018
- Exchange
- Stuttgart Exchange
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Employees
- 1,435
- Fiscal year end
- March
- Address
- Tower One, Causeway Bay, Hong Kong
- Phone
- 852 2583 9333
- Website
- alihealth.cn
About Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, appointment-booking, vaccination, dental care, mental care, optometry, and nursing services, as well as traditional Chinese medicines. The company provides is products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, software technical services, healthcare related internet information and technical services; operation of internet hospitals, as well as Doctor U, an intelligent and one-stop platform for doctor and patient education; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Alibaba Health Information Technology Limited management
8- Mr. Difan ShenExecutive Director · born 1978
- Mr. Yong YuCEO & Executive Chairman · born 1976
- Ms. Mengyue ShengCFO & Executive Director · born 1982
- Ms. Deng YanChief Legal Advisor & Joint Company Secretary
- Ms. Yin RuiChief Marketing Officer
- Ms. Zhang HuaChief People Officer
- Mr. Chun Chung KwongFinancial Controller
- Ms. Hiu Leong TsuiLegal Counsel & Joint Company Secretary